---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-21-003192"
form_type: "8-K"
ticker: "BDPT"
cik: "0001575142"
company_name: "BIOADAPTIVES, INC."
filed_at: "2021-12-16T23:59:59+00:00"
generated_at: "2026-06-28T00:31:49.436166+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# BioAdaptives enters marketing agreement for LungFlute medical device; plans LungArmor package

## Summary
- Marketing agreement with Acoustic Innovations LLC for LungFlute™ OscPEP device; rights in US, Canada, and other approved regions.
- Device is FDA-cleared, creates low-frequency acoustic energy to loosen mucus; used in $800K TB trial in Africa.
- BioAdaptives to market device as LungCleanser™ combined with PrimiLungs™ supplement as LungArmor™ package.
- No financial terms of the agreement disclosed in the filing.

## SEC filing metadata
- accession: 0001640334-21-003192
- form_type: 8-K
- ticker: BDPT
- cik: 0001575142
- company_name: BIOADAPTIVES, INC.
- filed_at: 2021-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1575142/000164033421003192/0001640334-21-003192-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1575142/000164033421003192/bdpt_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-21-003192
- JSON: https://secwatch.observer/filing/0001640334-21-003192.json
- Plain text: https://secwatch.observer/filing/0001640334-21-003192.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.